The many futures for cell-penetrating peptides: how soon is now?
- PMID:17635144
- DOI: 10.1042/BST0350767
The many futures for cell-penetrating peptides: how soon is now?
Abstract
Studies of CPPs (cell-penetrating peptides), sequences that are also commonly designated as protein transduction domains, now extend to a second decade of exciting and far-reaching discoveries. CPPs are proven vehicles for the intracellular delivery of macromolecules that include oligonucleotides, peptides and proteins, low-molecular-mass drugs, nanoparticles and liposomes. The biochemical properties of different classes of CPP, including various sequences derived from the HIV-1 Tat (transactivator of transcription) [e.g. Tat-(48-60), GRKKRRQRRRPPQ], and the homeodomain of the Drosophila homeoprotein Antennapaedia (residues 43-58, commonly named penetratin, RQIKIWFQNRRMKWKK), also provide novel insights into the fundamental mechanisms of translocation across biological membranes. Thus the efficacy of CPP-mediated cargo delivery continues to provide valuable tools for biomedical research and, as witnessed in 2007, candidate and emerging therapeutics. Thus it is anticipated that the further refinement of CPP technologies will provide drug-delivery vectors, cellular imaging tools, nanoparticulate devices and molecular therapeutics that will have a positive impact on the healthcare arena. The intention of this article is to provide both a succinct overview of current developments and applications of CPP technologies, and to illustrate key developments that the concerted efforts of the many researchers contributing to the Biochemical Society's Focused Meeting in Telford predict for the future. The accompanying papers in this issue of Biochemical Society Transactions provide additional details and appropriate references. Hopefully, the important and eagerly anticipated biomedical and clinical developments within the CPP field will occur sooner rather than later.
Similar articles
- Cell-penetrating peptides in drug development: enabling intracellular targets.Chen L, Harrison SD.Chen L, et al.Biochem Soc Trans. 2007 Aug;35(Pt 4):821-5. doi: 10.1042/BST0350821.Biochem Soc Trans. 2007.PMID:17635156Review.
- Transport molecules using reverse sequence HIV-Tat polypeptides: not just any old Tat? (WO200808225).Howl J, Jones S.Howl J, et al.Expert Opin Ther Pat. 2009 Sep;19(9):1329-33. doi: 10.1517/17530050902824829.Expert Opin Ther Pat. 2009.PMID:19555160Review.
- Recent advances in the use of cell-penetrating peptides for medical and biological applications.Fonseca SB, Pereira MP, Kelley SO.Fonseca SB, et al.Adv Drug Deliv Rev. 2009 Sep 30;61(11):953-64. doi: 10.1016/j.addr.2009.06.001. Epub 2009 Jun 16.Adv Drug Deliv Rev. 2009.PMID:19538995Review.
- Chances and pitfalls of cell penetrating peptides for cellular drug delivery.Tréhin R, Merkle HP.Tréhin R, et al.Eur J Pharm Biopharm. 2004 Sep;58(2):209-23. doi: 10.1016/j.ejpb.2004.02.018.Eur J Pharm Biopharm. 2004.PMID:15296950Review.
- Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.Chugh A, Eudes F, Shim YS.Chugh A, et al.IUBMB Life. 2010 Mar;62(3):183-93. doi: 10.1002/iub.297.IUBMB Life. 2010.PMID:20101631Review.
Cited by
- A molecular signature in the pannexin1 intracellular loop confers channel activation by the α1 adrenoreceptor in smooth muscle cells.Billaud M, Chiu YH, Lohman AW, Parpaite T, Butcher JT, Mutchler SM, DeLalio LJ, Artamonov MV, Sandilos JK, Best AK, Somlyo AV, Thompson RJ, Le TH, Ravichandran KS, Bayliss DA, Isakson BE.Billaud M, et al.Sci Signal. 2015 Feb 17;8(364):ra17. doi: 10.1126/scisignal.2005824.Sci Signal. 2015.PMID:25690012Free PMC article.
- DNA-interactive properties of crotamine, a cell-penetrating polypeptide and a potential drug carrier.Chen PC, Hayashi MA, Oliveira EB, Karpel RL.Chen PC, et al.PLoS One. 2012;7(11):e48913. doi: 10.1371/journal.pone.0048913. Epub 2012 Nov 8.PLoS One. 2012.PMID:23145017Free PMC article.
- Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cells.Rangel R, Guzman-Rojas L, le Roux LG, Staquicini FI, Hosoya H, Barbu EM, Ozawa MG, Nie J, Dunner K Jr, Langley RR, Sage EH, Koivunen E, Gelovani JG, Lobb RR, Sidman RL, Pasqualini R, Arap W.Rangel R, et al.Nat Commun. 2012 Apr 17;3:788. doi: 10.1038/ncomms1773.Nat Commun. 2012.PMID:22510693Free PMC article.
- Polyarginine molecular weight determines transfection efficiency of calcium condensed complexes.Alhakamy NA, Berkland CJ.Alhakamy NA, et al.Mol Pharm. 2013 May 6;10(5):1940-8. doi: 10.1021/mp3007117. Epub 2013 Apr 15.Mol Pharm. 2013.PMID:23534410Free PMC article.
- Scorpion venom components as potential candidates for drug development.Ortiz E, Gurrola GB, Schwartz EF, Possani LD.Ortiz E, et al.Toxicon. 2015 Jan;93:125-35. doi: 10.1016/j.toxicon.2014.11.233. Epub 2014 Nov 26.Toxicon. 2015.PMID:25432067Free PMC article.Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources